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A Novel Functional Link between MAP Kinase Cascades
and the Ras/cAMP Pathway that Regulates Survival
cAMP was 6-fold greater in the 1278b strain grown
on agar plates than in liquid culture, and this is consis-
tent with the hypothesis that the Ras/cAMP pathway is
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1Department of Biological Chemistry and hyperactivated during invasion [3, 17]. The fus3 muta-
tion caused a 1.5- to 1.7-fold increase in cAMP in bothMolecular Pharmacology
Harvard Medical School strain backgrounds, and the expression of catalytically
inactive Fus3K42R reversed the increase (Figure 1B). In240 Longwood Avenue
Boston, Massachusetts 02115 contrast, the kss1 mutation caused a 1.5- to 2.0-fold
decrease in cAMP in wild-type and fus3 strains, and
catalytically inactive Kss1K42R caused a further decrease
(Figure 1B). These changes in cAMP were physiologi-Summary
cally relevant; by comparison, a hyperactive RAS2val19
mutation caused a 1.7-fold increase in cAMP (FigureIn mammalian cells, Ras regulates multiple effectors,
including activators of mitogen-activated protein ki- 1B), as was previously reported [18]. Furthermore, they
correlated with changes in glycogen accumulation, asnase (MAPK) cascades, phosphatidylinositol-3-kinase,
and guanine nucleotide exchange factors (GEFs) for shown by reduced glycogen in a fus3 strain and in-
creased glycogen in kss1 strains (Figure 1C, compareRalGTPases [1, 2]. In S. cerevisiae, Ras regulates the
Kss1 MAPK cascade that promotes filamentous growth wild-type [WT] and kss1 and fus3 and fus3 kss1).
Thus, during vegetative and invasive growth, Fus3 re-and cell integrity [3, 4], but its major function is to ac-
tivate adenylyl cyclase and control proliferation and presses cAMP accumulation, even when inactive. In
contrast, catalytically active Kss1 positively regulatessurvival ([5–8; see Figure S1 in the Supplemental Data
available with this article online). Previous work hints cAMP, while inactive Kss1 is inhibitory.
We determined whether the changes in cAMP levelsthat the mating Fus3/Kss1 MAPK cascade cross-regu-
lates the Ras/cAMP pathway during growth [9] and in the fus3 and kss1mutants correlated with changes
in the status of the remaining MAPK. Immunoblot analy-mating [10–13], but direct evidence is lacking. Here,
we report that Kss1 and Fus3 act upstream of the sis of whole-cell extracts showed that fus3 cells had
elevated levels of active Kss1, whereas kss1 cells hadRas/cAMP pathway to regulate survival. Loss of Fus3
increases cAMP and causes poor long-term survival wild-type levels of active Fus3 (Figure 1E). The increase
in active Kss1 correlated with increased Kss1 proteinand resistance to stress. These effects are dependent
on Kss1 and Ras2. Activation of Kss1 by a hyperactive (Figure 1E) and was only partially reduced by a mutation
in the Tec1 transcription factor (Figure 1F) that upregu-Ste11 MAPKKK also increases cAMP, but mating re-
ceptor/scaffold activation has little effect and may lates the KSS1 gene and is regulated by Kss1 [19]. Kss1
was only slightly basally activated in the fus3K42R straintherefore insulate the MAPKs from cross-regulation.
Catalytically inactive Fus3 represses cAMP by block- (Figure 1E), similar to that of another mutant, fus3–211
(Figure 1F) [20]. Thus, the increase in cAMP in a fus3ing accumulation of active Kss1 and by another func-
tion also shared by Kss1. The conserved RasGEF strain correlates with loss of repression of total Kss1
activity, and much of this repression is by catalyticallyCdc25 [5, 6, 14–16] is a likely control point, because
Kss1 and Fus3 complexes associate with and phos- inactive Fus3. This finding is consistent with the majority
of Fus3 being inactive in the absence of pheromone [9].phorylate Cdc25. Cross-regulation of Cdc25 may be a
general way that MAPKs control Ras signaling net- A constitutively active allele of the Ste11 MAPKKK
(STE11-4) that activates Fus3, Kss1, and Hog1 MAPKworks.
[21] was used to test whether activation of Kss1 in-
creases cAMP levels. STE11-4 increased the activity ofResults and Discussion
Kss1 and Fus3 and had a greater effect on Kss1 (Figure
1F). The increase in Kss1 activity correlated with a 2-foldPrevious work suggested that a fus3 strain might have
increase in cAMP levels (Figure 1B) and a large decreaseelevated levels of cAMP because it was sensitive to
in glycogen accumulation (Figure 1D). A fus3 mutationstorage at 4C and was also hypersensitive to heat shock
further increased the level of cAMP (Figure 2A, STE11-4and nitrogen starvation if two major G1 cyclins (CLN1
versus STE11-4 fus3), whereas a kss1 mutation re-and CLN2) were deleted (Figure 1A) [9]. cAMP was quan-
duced it to wild-type levels (compare STE11-4 versustitated in haploid strains with null mutations in FUS3
STE11-4 kss1 and STE11-4 fus3 versus STE11-4and KSS1 that were either logarithmically growing in
fus3 kss1), showing that the increase in cAMP in theliquid medium (Figure 1B, W303a strains; Figure S2,
STE11-4 strain is due to heightened activation of Kss1.W303a and 1278b strains [in the Supplemental Data
Thus, activation of Kss1 by fus3 or STE11-4 increasesavailable with this article online]) or invasively growing
cAMP levels. This regulation is independent of Ste12, aon agar plates (Figure 1B, 1278b strains). The level of
downstream target of Kss1 and Fus3 (Figure S2C).
By contrast, mating pheromone ( factor) had little*Correspondence: elaine_elion@hms.harvard.edu
effect on the level of cAMP in WT, fus3, kss1, or fus32 Present address: Hinnebusch Laboratory, NIH/NICHD, Building 6A,
Room B1A-05, Bethesda, Maryland 20892-0001. kss1 strains, although minor changes were detected
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Figure 1. Mutations in FUS3 and KSS1 Alter cAMP and Glycogen Levels in W303 and 1278b Strains
(A) A cln1 cln2 strain does not survive in the absence of nitrogen when FUS3 is deleted. Cells were grown on YPD plates at 30C, then
transferred to YNB or YNB minus nitrogen plates. After 2 days, cells were replica plated to YPD plates. Strains: CY806 (cln1 cln2), CY808
(fus3 cln1 cln2).
(B) cAMP levels in vegetatively dividing W303a and invasively growing 1278b. Cells were grown in liquid selective SC media (W303 strains)
or on YPD agar plates (1278b strains), and cAMP levels were determined. Samples were done in subsets and were normalized to internal
controls. W303 strains: EY1118 (WT)  YCp50 (URA3 CEN), EY940 (fus3)  YCp50, EY940  pRT5 (fus3K42R URA3 CEN), EY966 (fus3
kss1)  YCp50, and CY533 (ras2)  #976 (RAS2V19 URA3 CEN). 1278b strains: 10560-4A (WT), YM105 (kss1), YM106 (fus3),
YM106  pRT5 (fus3K42R URA3 CEN), YM105  pkss1 (KSS1K42R HIS3 CEN), and YM107 (fus3 kss1). far1 strains: W303a EY1298
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Figure 2. Kss1-MYC and Fus3-HA Associate with GST-Cdc25 and GST-Gpa2
(A) Kss1-MYC in GST-Cdc25 complexes.
(B) GST-Cdc25 in Kss1-MYC complexes. Strains: EY966 harboring plasmids: lanes 1–3, Kss1-MYC  GST-Cdc25; lanes 4–6, Kss1 AEF-MYC 
GST-Cdc25; lane 7, GST  Kss1-MYC; lane 8, GST  Kss1 AEF-MYC; lane 9, GST-Cdc25.
(C) Fus3-HA in GST-Cdc25 complexes.
(D) GST-Cdc25 in Fus3-HA complexes. Strains: EY941 harboring the following plasmids: lanes 1–3, Fus3-HA  GST-Cdc25; lanes 4–6, FUS3
K42R-HA  GST-Cdc25; lane 7, GST  Fus3-HA; lane 8, GST  FUS3 K42R-HA; lane 9, GST-Cdc25.
(E and F) Association of GST-Gpa2 with Kss1 and Fus3. Cells were pregrown for 3–4 hr in galactose medium to induce expression of GST-
Cdc25 and Kss1-MYC. Extracts were made from cells without ( factor) or with ( factor) exposure to 100 nM  factor for 15 or 90 min.
The top panels show the coimmunoprecipitated protein, and the bottom panels show the protein immunoprecipitated directly from whole-
cell extracts.
The bottom panels of (B) and (D) and the right bottom panel of (E) serve as controls to (A), (C), and (E) (left), respectively; the bottom panels
of (A), (C), and (E) (left) serve as controls to (B), (D), and (E) (right), respectively.
(Figure S2D, data not shown). The negligible effect of  that the receptor-G protein-Ste5 scaffold signaling sys-
tem insulates Kss1 and Fus3 from cross-regulating thefactor on cAMP levels sharply contrasted the very large
increases in the activities of Kss1 and Fus3 detected as Ras/cAMP pathway.
The fact that the fus3 kss1 double mutant had aa result of  factor exposure (Figure 1F,  factor).
The maintenance of cAMP homeostasis during mating higher level of cAMP than the kss1 single mutant indi-
cated that Fus3 also regulates cAMP through a functionpheromone activation raises the interesting possibility
(STE11-4 far1), EY1321 (STE11-4 far1 fus3), EY1335 (STE11-4 far1 kss1), and EY1346 (STE11-4 far1 fus3 kss1).
(C and D) fus3 and STE11-4 mutations decrease the level of glycogen based on decreased iodine staining. Strains are Ade derivatives of
EY699 (WT), EY700 (fus3), EY725 (kss1), EY966 (fus3 kss1), EY1262 (STE11 far1), and EY1298 (STE11-4 far1). EY699 and EY1262
stained similarly.
(E and F) Activation of Kss1 correlates with increased cAMP. Relative activation of Kss1 and Fus3 measured with anti-active MAPK antibody.
Tcm1 is a ribosomal protein and serves as a loading control. Cells were induced with 100 nM  factor for 1 hr where indicated. Strains: EY1118
(WT), EY1119 (kss1), EY940 (fus3), EY1298 (STE11-4 far1), EY940  pRT5 (fus3K42R URA3 CEN), BY351 (fus3-211), and CY782 (fus3
tec1).
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Figure 3. Kss1 and Fus3 Phosphorylate
Cdc25
(A) Relative levels of active Kss1-MYC before
and after 15 min  factor induction. Kss1-
MYC and Kss1AEF-MYC immune complexes
were assayed as described in the Experimen-
tal Procedures (see the Supplemental Data).
(B) In vitro phosphorylation of yeast GST-
Cdc25 by Fus3-HA immune complexes. GST-
Cdc25 was purified from a fus3 kss1 strain
(EY966) and was incubated with Fus3-HA or
Fus3K42R-HA immune complexes in a kinase
assay. Fus3-HA (lanes 2 and 4) or Fus3 K42R-
HA (lanes 3 and 5) immunoprecipitated from
extracts made from EY966 harboring FUS3-
HA and FUS3, respectively. Cells were in-
duced with 100 nM  factor for 1 hr where
indicated. The in vitro substrates are endoge-
nous proteins that coprecipitate with kinases.
(C) Phosphorylation of E. coli-expressed
GST-Cdc25 by Kss1-MYC and Fus3-HA im-
mune complexes. GST-Cdc25 was purified
from E. coli and was immunoprecipitated with
anti-GST antibodies. GST-Cdc25 and Kss1-
MYC (or Fus3-HA) bound to protein A Sepha-
rose beads were mixed and incubated in the
kinase assay. Kss1-MYC or Kss1AEF-MYC
(left panel) and Fus3-HA or Fus3 K42R-HA
(right panel) immunoprecipitates made from
cells that had been incubated without () or
with () 100 nM -factor for 1 hr.
distinct from attenuation of Kss1. We therefore looked Fus3-HA immune complexes in the kinase assay. GST-
Cdc25 was phosphorylated at a low background levelfor physical interactions between Kss1, Fus3, and regu-
lators of cAMP synthesis. Remarkably, specific interac- when assayed alone (Figure 3B, lanes 5 and 6). Active
Fus3-HA further increased the amount of phosphory-tions were detected between both MAPKs and Cdc25,
but not with Ras2 or Gpa2 in a Gal4-based two-hybrid lated GST-Cdc25 (Figure 3B, lane 4), whereas inactive
Fus3R42-HA did not (Figure 3B, lane 3). Furthermore,system (Figure S3). These interactions were confirmed
in coprecipitation tests with functional tagged deriva- GST-Cdc25 expressed in E. coli was phosphorylated in
vitro by Kss1-Myc and Fus3-HA immune complexes thattives of Cdc25 (GST-Cdc25), Kss1 (Kss1-MYC), and
Fus3 (Fus3-HA) (Figures 2A–2D). Cdc25 also associated had been stripped of associated substrates (Figure 3C),
whereas GST was not phosphorylated in a parallel ex-with unactivatable Kss1AEF-MYC and catalytically inac-
tive Fus3K42R-HA (Figures 2A–2D). The association of periment (data not shown). Thus, Cdc25 is likely to di-
rectly associate with Kss1 and Fus3 and may be an inKss1 and Fus3 with Cdc25 is likely to be physiologically
relevant, because it was highly reproducible and de- vivo substrate of both MAPKs.
To test whether Fus3 negatively regulates cAMP attected when the coimmunoprecipitations were done in
both directions ([A] and [C] versus [B] and [D]) under the Cdc25 step, we compared glycogen accumulation
in fus3 and ras2 single and double mutants in theconditions in which the level of GST-Cdc25 matched
that of Fus3-HA, which was at native levels (Experimen- W303a strain background. As expected, the ras2 strain
had more glycogen than wild-type, while the fus3 straintal Procedures). Thus, Cdc25 may be bound in vivo by
both the active and inactive forms of the MAPKs. Fus3 had less glycogen (Figure 4A). The fus3 ras2 double
mutant accumulated as much if not more glycogen thanand Kss1 also associated with Gpa2 (Figures 2E and
2F), which positively regulates adenylyl cyclase during the ras2 single mutant; this finding is consistent with
Fus3 acting upstream of Ras2. Long-term survival underfilamentous growth and may also interact with Cdc25
[22]. This interaction may be indirect, based on two- conditions of 2% dextrose in liquid medium is extended
by mutations in adenylate cyclase [23]. Fus3 is requiredhybrid tests.
Kss1 and Fus3 were tested for their ability to phos- for survival on SC or YPD plates containing 2% dextrose
(E.A.E., unpublished data) [9], suggesting that it is aphorylate GST-Cdc25 in immune complexes isolated
from cells that had been pretreated with  factor to secondary effect of increased cAMP. We therefore
quantitated the long-term survival of fus3 cells in liquidgenerate active kinase. Kss1 was efficiently activated
by factor and yielded a profile of associated substrates SC medium containing 2% dextrose. Strikingly, the via-
bility of the fus3 strain over time was significantly re-similar, but not identical, to that of Fus3 (Figures 3A and
3B, lanes 1 and 2). This profile is in agreement with duced compared to wild-type, demonstrating that Fus3
plays a critical role in long-term survival (Figure 4B). Tofunctional overlap between the two MAPKs ([9, 20] and
[S15, S19], in the Supplemental Data). GST-Cdc25 was determine whether the inviability of the fus3 strain was
due to activation of Kss1 and increased cAMP, the sur-purified from fus3 kss1 extracts and was added to
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Figure 4. Fus3 Promotes Long-Term Survival through Kss1 and Ras2
(A) The effect of a fus3 mutation on glycogen accumulation is blocked by a ras2 mutation. Strains were streaked on the same SC-complete
plate and were incubated at 30C for 2 days and then exposed to iodine vapors.
(B) A fus3 mutation reduces long-term survival in the presence of Kss1 and Ras2. Strains were grown as described in the Experimental
Procedures (see the Supplemental Data).
(C) A fus3 ras2 double mutant has a normal growth rate but a slightly enhanced lag phase. Strains were grown in YPD medium.
(D) A fus3 ras2 double mutant is hypersensitive to temperature shock. Strains were grown on solid YPD at 30C, then replica plated onto
either solid YPD at 55C for 2 hr or YPD at 4C for 2 days. Cells were then replica plated to a YPD plate and incubated at room temperature
for several days and photographed. Strains: EY957 (WT), EY940 (fus3), EYL1463/CY533 (ras2), EYL1464/CY534 (fus3 ras2).
(E and F) Summary of potential interactions between MAPKs Kss1 and Fus3 and the GEF Cdc25.
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vival of the fus3 strain was compared to that of fus3 direct effect on Cdc25 function or an indirect one, such
as blocking access by other regulators. Preliminary ex-kss1 and fus3 ras2 double mutants. Remarkably, a
kss1 mutation restored wild-type survival to the fus3 periments support the possibility that the regulation of
the S. cerevisiae Ras pathway by Fus3 and Kss1 mightstrain, and the ras2 mutation restored partial survival,
suggesting that Kss1 and Ras2 function downstream of be part of a more general hierarchy of control that is
shared by other MAPKs.Fus3 to regulate survival (Figure 4B).
These findings support a regulatory hierarchy in which
Supplemental DataFus3 and Kss1 regulate cAMP levels at the Cdc25 step
Supplemental Data including a summary of the Ras/cAMP and the(Figure 4E). Positive regulation of cAMP signaling by
Kss1/Fus3 signaling pathways (Figure S1), the effect of  factor
Kss1 is predicted to promote proliferation and could stimulation on cAMP levels (Figure S2), two-hybrid interactions be-
also provide a second homeostatic mechanism that ad- tween Cdc25 and both Kss1 and Fus3 (Figures S3), and the effect of
justs the level of signaling during filamentous growth in a fus3 mutation on glycogen accumulation and growth of a cdc25-1
mutant (Figure S4) are available at http://www.current-biology.parallel with protein kinase A [3, 6]. A resultant increase
com/cgi/content/full/13/14/1220/DC1/.in cAMP is predicted to enforce a developmental switch
from vegetative growth to foraging.
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